BTK and rheumatoid arthritis: Most studies investigating BTK inhibitors in RA, based on a collagen induced arthritis (CIA) rodent model, indicate that BTKis inhibit B-cell activation, myeloid immune complexes’ formation, decrease inflammatory cytokine activity, and stimulate osteoclastogenesis [28,73,78,79,105].